当前位置: X-MOL 学术Tuberculosis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Biomarkers to predict FDG PET/CT activity after the standard duration of treatment for spinal tuberculosis: An exploratory study
Tuberculosis ( IF 2.8 ) Pub Date : 2021-07-08 , DOI: 10.1016/j.tube.2021.102107
Theresa N Mann 1 , James Warwick 2 , Novel N Chegou 3 , Johan H Davis 1 , Caroline G G Beltran 3 , Stephanie Griffith-Richards 4 , Martin Kidd 5 , Jacques du Toit 6 , Robert P Lamberts 6 , Gerhard Walzl 3
Affiliation  

Objectives

18F-Fluorodeoxyglucose (FDG) Positron Emission Tomography- Computed Tomography (PET/CT) scans can be used to assess healing following treatment for spinal tuberculosis (TB) but have limited accessibility and high cost. This study investigated the association between immune biomarkers and FDG-PET/CT activity after ≥9 months of treatment for spinal TB.

Methods

Patients who had completed ≥9 months of treatment for spinal TB were recruited from a major hospital in the Western Cape, South Africa. Participants underwent a FDG-PET/CT scan and FDG- PET/CT activity was quantified for all spinal and extra-spinal sites. Participants also provided a blood sample, which was evaluated for 19 cytokines along with erythrocyte sedimentation rate (ESR). Correlations and multiple regression analyses were used to investigate the association between biomarkers and PET/CT measures.

Results

Twenty-eight patients were recruited, of whom 24 (86%) had spinal and/or extra-spinal FDG-PET/CT activity. In the strongest multiple regression model, CXCL10/IP-10, VEGFA, IFN-γ, CRP and Factor D/Adipsin explained 52% of the variation in overall maximal FDG uptake. Conventional monitoring marker ESR showed no significant association with PET/CT measures.

Conclusions

The current findings offered encouragement that biomarkers to predict FDG-PET/CT activity may show some promise and identified candidate biomarkers for further investigation in this regard.



中文翻译:

预测脊柱结核标准治疗持续时间后 FDG PET/CT 活动的生物标志物:一项探索性研究

目标

18F-氟脱氧葡萄糖 (FDG) 正电子发射断层扫描 - 计算机断层扫描 (PET/CT) 扫描可用于评估脊柱结核 (TB) 治疗后的愈合情况,但可获得性有限且成本高。本研究调查了脊柱结核治疗≥9 个月后免疫生物标志物与 FDG-PET/CT 活性之间的关联。

方法

从南非西开普省的一家大医院招募了完成 ≥9 个月脊柱结核治疗的患者。参与者接受了 FDG-PET/CT 扫描,并对所有脊柱和脊柱外部位的 FDG-PET/CT 活动进行了量化。参与者还提供了血液样本,评估了 19 种细胞因子以及红细胞沉降率 (ESR)。相关性和多元回归分析用于研究生物标志物与 PET/CT 测量之间的关联。

结果

招募了 28 名患者,其中 24 名 (86%) 有脊髓和/或脊髓外 FDG-PET/CT 活动。在最强的多元回归模型中,CXCL10/IP-10、VEGFA、IFN-γ、CRP 和因子 D/Adipsin 解释了总体最大 FDG 摄取量变化的 52%。常规监测标志物 ESR 与 PET/CT 测量没有显着相关性。

结论

目前的研究结果鼓励了预测 FDG-PET/CT 活性的生物标志物可能显示出一些前景,并确定了在这方面进一步研究的候选生物标志物。

更新日期:2021-07-12
down
wechat
bug